FR2547819B1 - Acides 3-acylamino-2-oxoazetidine-1-b-oxopropioniques a proprietes therapeutiques - Google Patents

Acides 3-acylamino-2-oxoazetidine-1-b-oxopropioniques a proprietes therapeutiques

Info

Publication number
FR2547819B1
FR2547819B1 FR8409029A FR8409029A FR2547819B1 FR 2547819 B1 FR2547819 B1 FR 2547819B1 FR 8409029 A FR8409029 A FR 8409029A FR 8409029 A FR8409029 A FR 8409029A FR 2547819 B1 FR2547819 B1 FR 2547819B1
Authority
FR
France
Prior art keywords
oxoazetidine
acylamino
therapeutic properties
oxopropionic
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8409029A
Other languages
English (en)
Other versions
FR2547819A1 (fr
Inventor
Uwe D Treuner
Hermann Breuer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2547819A1 publication Critical patent/FR2547819A1/fr
Application granted granted Critical
Publication of FR2547819B1 publication Critical patent/FR2547819B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8409029A 1983-06-13 1984-06-08 Acides 3-acylamino-2-oxoazetidine-1-b-oxopropioniques a proprietes therapeutiques Expired FR2547819B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/503,964 US4534896A (en) 1983-06-13 1983-06-13 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)

Publications (2)

Publication Number Publication Date
FR2547819A1 FR2547819A1 (fr) 1984-12-28
FR2547819B1 true FR2547819B1 (fr) 1986-07-25

Family

ID=24004273

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8409029A Expired FR2547819B1 (fr) 1983-06-13 1984-06-08 Acides 3-acylamino-2-oxoazetidine-1-b-oxopropioniques a proprietes therapeutiques

Country Status (7)

Country Link
US (1) US4534896A (fr)
JP (1) JPS6016969A (fr)
CA (1) CA1244036A (fr)
DE (1) DE3421785A1 (fr)
FR (1) FR2547819B1 (fr)
GB (1) GB2141428B (fr)
IT (1) IT1180190B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559335A (en) * 1983-10-03 1985-12-17 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethyloxy (or thio) carbonyl-2-azetidinones
US5229381A (en) * 1983-12-01 1993-07-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5229510A (en) * 1983-12-01 1993-07-20 Merck & Co., Inc. β-lactams useful in determining the amount of elastase in a clinical sample
US5100880A (en) * 1991-03-20 1992-03-31 Merck & Co., Inc. Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5104862A (en) * 1991-03-20 1992-04-14 Merck & Co., Inc. Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5348953A (en) * 1991-06-25 1994-09-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
CA2147129A1 (fr) * 1992-10-27 1994-05-11 James B. Doherty Nouvelles azetidinones substituees utilisees comme agents anti-inflammatoires et anti-degeneratifs
US5591737A (en) * 1992-12-17 1997-01-07 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5747485A (en) * 1995-04-13 1998-05-05 Merck & Co., Inc. Substituted azetidiones as anti-inflammatory and antidegenerative agents
US6022271A (en) * 1997-07-07 2000-02-08 Biondo; Vincent C. Fire responsive closing air vent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532551A (en) * 1976-06-28 1978-01-11 Sekisui Chem Co Ltd Method of improving inorganic filler
BE869503A (fr) * 1977-11-18 1978-12-01 Farmaceutici Italia Nouvelles azetidinones et leur application en synthese organique
NZ199981A (en) * 1981-04-09 1985-08-16 Squibb & Sons Inc 2-oxo-1-(((substituted sulphonyl)amino)carbonyl)azetidines
CA1272726C (fr) * 1982-01-04 1990-08-14 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl) azetidines
US4939253A (en) * 1982-08-04 1990-07-03 E. R. Squibb & Sons, Inc. 2-oxoazetidin-1-yloxy acetic acids and analogs

Also Published As

Publication number Publication date
GB2141428B (en) 1986-10-22
US4534896A (en) 1985-08-13
GB8412501D0 (en) 1984-06-20
IT1180190B (it) 1987-09-23
JPS6016969A (ja) 1985-01-28
FR2547819A1 (fr) 1984-12-28
CA1244036A (fr) 1988-11-01
DE3421785A1 (de) 1984-12-13
GB2141428A (en) 1984-12-19
IT8421387A0 (it) 1984-06-13

Similar Documents

Publication Publication Date Title
FR2617721B1 (fr) Catheter
KR890701156A (ko) 멀티-루멘(multi-lumen) 경막외-척추 주사바늘
PT88672A (pt) Syringe
DE10075034I1 (de) Insulinderivate
IT1196613B (it) Calze terapeutiche
IT1182965B (it) Dispositivo terapeutico magnetico
FR2547819B1 (fr) Acides 3-acylamino-2-oxoazetidine-1-b-oxopropioniques a proprietes therapeutiques
KR880018963U (ko) 바늘 케이스
FR2516924B1 (fr) Acides phosphinylalcanoyl- amines a action therapeutique
DK651188A (da) Disulfidholdige pro-laegemidler med antitumorvirkning
DK327488A (da) Kanyle
FR2550195B1 (fr) Acides (2-oxo-1-azetidinyloxy)-2-propenoiques a proprietes therapeutiques
FR2533566B1 (fr) Imino- et amino-acides acyloxycetone-substitues a action therapeutique
FR2602232B1 (fr) Acides n-nicotinoylamines
DK42786A (da) Terapivandseng
DK85290D0 (da) Terapeutisk virksomme forbindelser
ATA266987A (de) Matratze
KR850001234U (ko) 자침용 침관
BR8700602A (pt) Cura magnetica
KR890006371U (ko) 포장침
KR880017976U (ko) 바늘
SE8300779D0 (sv) Kanyl
BR8707218A (pt) Agulha magica
FR2551750B1 (fr) 3-acylamino-2-oxo-1-azetidinyl-b-oxypropionates a action therapeutique
SE8701737D0 (sv) Kanyl

Legal Events

Date Code Title Description
ER Errata listed in the french official journal (bopi)

Free format text: 52/84

ST Notification of lapse